Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Vasogen to begin clinical trial with VAS-991 for treatment of congestive heart failure

Jan. 20, 2000

Potassium channel inhibitors for arrhythmias emerge from ICAgen/Lilly collaboration

Jan. 20, 2000

Efforts at DuPont to design potent and selective alphavbeta3 antagonists successful

Jan. 19, 2000

Avant Immunotherapeutics reports on TP-10 progress

Jan. 19, 2000

Pre- and postischemic treatment with FR-183998 cardioprotective in rat models

Jan. 18, 2000

Sangamo and Baxter to collaborate on novel vascular disease therapeutics

Jan. 18, 2000

Avant Immunotherapeutics updates progress with CETi-1

Jan. 18, 2000

Collateral Therapeutics boosts cardiovascular gene therapy portfolio with new patent

Jan. 17, 2000

Health Canada grants priority review to Vanlev

Jan. 14, 2000

Myriad Genetics and Roche to collaborate on cardiovascular drug discovery

Jan. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...